A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer.
Speyer
J L
JL
Rita and Stanley H. Kaplan Cancer Center, New York, NY 10016.
Green
M D
MD
Sanger
J
J
Zeleniuch-Jacquotte
A
A
Kramer
E
E
Rey
M
M
Wernz
J C
JC
Blum
R H
RH
Hochester
H
H
Meyers
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D009202:Cardiomyopathies / Q000139:chemically induced / Q000517:prevention & control*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006321:Heart / Q000187:drug effects*; D006801:Humans; D011446:Prospective Studies; D011929:Razoxane / Q000627:therapeutic use*
D011929:Razoxane; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil